While regulatory standards are essential, they also present certain challenges:
Time and Cost: The process of getting a new cancer drug approved can be lengthy and expensive, often taking several years and significant financial investment. Innovation vs. Safety: Balancing the need for rapid innovation in cancer treatment with the necessity of ensuring safety and efficacy. Global Variability: Different countries have different regulatory standards, which can complicate the global development and distribution of cancer therapies.
